VALENCE, France--(BUSINESS WIRE)--Regulatory News:
Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible), the French market leader in surgical technologies for lower limb orthopedics, announces its financial agenda for the 2024-25 financial year.
Events |
Dates * |
|
2024-25 Q1 Sales |
Thursday, November 21, 2024 |
|
2024-25 H1 Sales |
Thursday, February 20, 2025 |
|
2024-25 H1 Results |
Wednesday, March 26, 2025 |
|
2024-25 Q3 Sales |
Thursday, April 17, 2025 |
|
2024-25 Full-year Sales |
Thursday, July 24, 2025 |
|
2024-25 Full-Year results |
Wednesday, October 22, 2025 |
|
2025-26 Q1 Sales |
Thursday, November 20, 2025 |
* Subject to change. Press releases are published after market close.
Next press release:
2024-25 Q1 Sales: Thursday, November 21, 2024, after market close.
About Amplitude Surgical
Founded in 1997 in Valence, France, Amplitude Surgical is a leading French player in the global market for orthopedic surgical technologies for the lower limbs. Amplitude Surgical develops and markets high-end products for orthopedic surgery, covering the main pathologies affecting the hip and knee. Working in close collaboration with surgeons, Amplitude Surgical develops numerous high value-added innovations to meet the needs of patients, surgeons and care facilities. A leading player in France, Amplitude Surgical is expanding internationally through its subsidiaries and a network of agents and exclusive distributors in over 30 countries. At June 30, 2024, Amplitude Surgical employed 428 people and generated sales of nearly 106.0 million euros.
